21 results
10-KT
RCEL
AVITA Medical Inc
28 Feb 22
Annual report (with FYE transition)
4:11pm
cost, if at all. Defense of any lawsuit or failure to obtain any of these licenses could prevent us from commercializing available products and have
10-KT
EX-10.14
RCEL
AVITA Medical Inc
28 Feb 22
Annual report (with FYE transition)
4:11pm
or investigating a suspected violation of la w; or (ii) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Executive … is further notified that if Executive files a lawsuit for retaliation by an employer for reporting a suspected violation of law, Executive may
10-KT
EX-10.15
RCEL
AVITA Medical Inc
28 Feb 22
Annual report (with FYE transition)
4:11pm
in a lawsuit or other proceeding. Executive is further notified that if Executive files a lawsuit for retaliation by an employer for reporting a suspected
8-K
EX-10.1
yx90zaiyl r8ja0
24 Mar 21
AVITA Medical, Inc. Names Michael Holder as Chief Financial Officer
11:47am
8-K
EX-1.1
p7svx9j72q2pec
1 Mar 21
Avita Medical, Inc. Announces Pricing of Its Public Offering of
4:05pm
8-K
EX-10.1
q6ws36nkuwb
2 Dec 20
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
11:01am
10-K
x5nqq8h fso9qph
27 Aug 20
Annual report
12:00am
20-F
nrwcfp07ee10yn s4
31 Oct 19
Annual report (foreign)
3:49pm
20FR12B/A
h86fzxea7rpfq4vihah0
27 Sep 19
Initial registration of securities (foreign private issuers) (amended)
4:13pm
20FR12B/A
rkl0lo1jr6s15
25 Sep 19
Initial registration of securities (foreign private issuers) (amended)
6:07am
20FR12B
EX-4.9
k2hgs1s6myy55j9
19 Sep 19
Initial registration of securities (foreign private issuers)
4:43pm
20FR12B
us90astq
19 Sep 19
Initial registration of securities (foreign private issuers)
4:43pm
DRS/A
1ilj4psb74nnqvs9
11 Sep 19
Draft registration statement (amended)
12:00am
DRS/A
EX-4.9
w683brzk
11 Sep 19
Draft registration statement (amended)
12:00am
DRS/A
c40xe6er23gxw0jut93v
23 Aug 19
Draft registration statement (amended)
12:00am